LIAI scientists identify immune system trigger for fighting Lyme diseaseAugust 22, 2006Research could lead to new vaccines against Lyme disease and other bacterial infections Researchers at the La Jolla Institute for Allergy & Immunology (LIAI) today announced an important finding on Lyme disease that could eventually lead to the development of a new vaccine to prevent this tick-borne disorder. Lyme disease is transmitted to humans by the bite of infected ticks. Typical symptoms include fever, headache, fatigue, and sometimes skin rashes. If left untreated, it can spread to the joints, the heart and the nervous system and can lead to serious health problems. LIAI scientist Mitchell Kronenberg, Ph.D., and an international team of scientists, have identified that Borrelia burgdorferi, the bacteria that causes Lyme disease, contains a glycolipid which triggers an immune response from the body's natural killer (NK) T cells, a type of white blood cell. The finding is particularly exciting because it is one of the few glycolipids found to naturally induce an immune response from the body's NK T cells, which are prized for their ability to initiate a fast and vigorous attack against infection. Scientists are hopeful that this glycolipid can be used to create a vaccine against Lyme disease.
The finding was published today in the online version of the scientific journal Nature Immunology in a paper entitled, "Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria." This was the second major finding on NK T cells published in the last year by Kronenberg and his team. In a June 2005 scientific paper in Nature, Kronenberg and colleagues identified a bacteria, Sphingomonas, as containing a glycolipid which also triggers an NK T cell response. Now that a total of three substances have been found to naturally activate the NK T cells, "it opens up the idea that we should be looking at many different types of bacteria that may be able to activate these cells," Kronenberg said. Most white blood cells respond to foreign proteins to protect the body, but NK T cells are unique in that they respond to glycolipids, which are natural biochemicals made of linked fat and sugar. Prior to Kronenberg's findings, only one compound, developed by the Kirin Pharmaceutical Research company in the1990s, was known to activate the NK T cells. In a surprising twist, that compound was initially discovered in marine sponges. The compound was found to have anti-tumor activity and is currently in clinical trials for several tumor types. Because the NK T cells are known to be responsible for the tumor fighting mechanism induced by the marine sponge compound, and because their mechanism of action has been so mysterious, the NK T cells have generated increased research interest over the last several years. In particular, scientists wanted to know what substance would naturally activate the NK T cells. "Although the synthetic compound was useful for many studies, we wanted to know what substance would normally cause the NK T cells to produce an immune response, and it was not believable that marine sponges normally stimulate our immune system," said Kronenberg, who is also LIAI's President and Scientific Director. After identifying the Sphingomonas bacteria last year as an NK T cell activator, Kronenberg strongly suspected that other bacteria might also activate these cells, which led to the discovery of the Borrelia burgdorferi antigen. He believes many other types of bacteria may also produce an immune response from NK T cells. "This is an exciting possibility that needs to be further explored as it could lead to the development of vaccines or treatments for many bacteria caused diseases," he said. Scientists from the Scripps Research Institute, Rockefeller University, the National Institutes of Health, Albany Medical College, Harvard Medical School, and Industrial Research Ltd of New Zealand also participated in the study. La Jolla Institute for Allergy and Immunology | |||||||||||||||||||||
|
Related Lyme Disease Current Events and Lyme Disease News Articles Study: Bird diversity lessens human exposure to West Nile Virus A study by biologists at Washington University in St. Louis shows that the more diverse a bird population is in an area, the less chance humans have of exposure to West Nile Virus (WNV). 'Deadly dozen' reports diseases worsened by climate change Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies. UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome A UC Riverside-led team of biomedical scientists has found that a readily available drug called minocycline, used widely to treat acne and skin infections, can be used to treat Fragile X syndrome, the most common inherited cause of mental impairment and the most common cause of autism. Diversity among bird populations found to reduce threat of West Nile virus A biologist and undergraduate student have discovered that what's good for an area's bird population is also good for people living nearby. Researchers track Lyme disease spirochetes Microbiologists at the University of Calgary have demonstrated the first direct visualization of the dissemination of Borrelia burgdorferi, the bacterium that causes Lyme disease. Drug prevents dangerous tick diseases Lyme disease is the blight of countryside users but it may be prevented with a single injection, according to research published in the Journal of Medical Microbiology. University of Pennsylvania Study Reveals Inconspicuous Hosts in the Lyme Disease Epidemic A study led by a University of Pennsylvania biologist in the tick-infested woods of the Hudson Valley is challenging the widely held belief that mice are the main animal reservoir for Lyme disease in the U.S. First placebo-controlled study of cognitive impairment due to chronic Lyme disease Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis. Water, air and soil pollution causes 40 percent of deaths worldwide, Cornell research survey finds About 40 percent of deaths worldwide are caused by water, air and soil pollution, concludes a Cornell researcher. Such environmental degradation, coupled with the growth in world population, are major causes behind the rapid increase in human diseases, which the World Health Organization has recently reported. "Combination" Lyme Disease Vaccine Proteins Patented Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease. More Lyme Disease Current Events and Lyme Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||